{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T13:37:43Z","timestamp":1785159463176,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"Shiraz University and Immunology Research Center (IRC), Tabriz University of Medical Sciences, Tabriz, Iran"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.biopha.2017.01.030","type":"journal-article","created":{"date-parts":[[2017,1,13]],"date-time":"2017-01-13T16:45:28Z","timestamp":1484325928000},"page":"34-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Therapeutic effects of bach1 siRNA on human breast adenocarcinoma cell line"],"prefix":"10.1016","volume":"88","author":[{"given":"Mansoor","family":"Aletaha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behzad","family":"Mansoori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Fazeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behzad","family":"Baradaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2017.01.030_bib0005","first-page":"133","article-title":"Cytotoxic activities of selected medicinal plants from Iran and phytochemical evaluation of the most potent extract","volume":"4","author":"Sahranavard","year":"2009","journal-title":"Res. Pharm. Sci."},{"key":"10.1016\/j.biopha.2017.01.030_bib0010","doi-asserted-by":"crossref","first-page":"163","DOI":"10.7150\/ijms.3827","article-title":"Cancer survivors in the United States: a review of the literature and a call to action","volume":"9","author":"Valdivieso","year":"2012","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.biopha.2017.01.030_bib0015","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1200\/JCO.2008.21.2134","article-title":"Clinical cancer advances 2008: major research advances in cancer treatment, prevention, and screening\u2014a report from the American Society of Clinical Oncology","volume":"27","author":"Winer","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.biopha.2017.01.030_bib0020","first-page":"52","article-title":"Breast cancer statistics 2013","volume":"64","author":"DeSantis","year":"2014","journal-title":"CA: Cancer J. Clin."},{"key":"10.1016\/j.biopha.2017.01.030_bib0025","series-title":"Breast Cancer Metastasis and Drug Resistance Progress and Prospects","year":"2013"},{"key":"10.1016\/j.biopha.2017.01.030_bib0030","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0025-7753(08)76433-9","article-title":"An\u00e1lisis de la incidencia, la supervivencia y la mortalidad seg\u00fan las principales localizaciones tumorales, 1985\u20132019: c\u00e1ncer de mama","volume":"131","author":"Izquierdo","year":"2008","journal-title":"Med. Cl\u00edn."},{"key":"10.1016\/j.biopha.2017.01.030_bib0035","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bbrc.2004.09.022","article-title":"Heme-dependent up-regulation of the \u03b1-globin gene expression by transcriptional repressor Bach1 in erythroid cells","volume":"324","author":"Tahara","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2017.01.030_bib0040","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.1128\/MCB.16.11.6083","article-title":"Bach proteins belong to a novel family of BTB-basic leucine zipper transcription factors that interact with MafK and regulate transcription through the NF-E2 site","volume":"16","author":"Oyake","year":"1996","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.biopha.2017.01.030_bib0045","doi-asserted-by":"crossref","first-page":"33533","DOI":"10.1074\/jbc.M112.392332","article-title":"Transcriptional network analysis identifies BACH1 as a master regulator of breast cancer bone metastasis","volume":"287","author":"Liang","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2017.01.030_bib0050","first-page":"243","article-title":"Therapeutic effects of myeloid cell leukemia-1 siRNA on human acute myeloid leukemia cells","volume":"4","author":"Karami","year":"2014","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/j.biopha.2017.01.030_bib0055","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1368-7646(02)00049-3","article-title":"Survivin expression and resistance to anticancer treatments: perspectives for new therapeutic interventions","volume":"5","author":"Zaffaroni","year":"2002","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.biopha.2017.01.030_bib0060","first-page":"00","article-title":"HMGI-C suppressing induces P53\/caspase9 axis to regulate apoptosis in breast adenocarcinoma cells","author":"Mansoori","year":"2016","journal-title":"ABBV Cell Cycle"},{"key":"10.1016\/j.biopha.2017.01.030_bib0065","series-title":"Silencing of High Mobility Group Isoform IC (HMGI-C) Enhances Paclitaxel Chemosensitivity in Breast Adenocarcinoma Cells (MDA-MB-468)","author":"Mansoori","year":"2016"},{"key":"10.1016\/j.biopha.2017.01.030_bib0070","first-page":"1","article-title":"SiRNA-mediated silencing of Snail-1 induces apoptosis and alters micro RNA expression in human urinary bladder cancer cell line","author":"Musavi Shenas","year":"2016","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.biopha.2017.01.030_bib0075","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/1471-2105-12-243","article-title":"RegNetB: predicting relevant regulator-gene relationships in localized prostate tumor samples","volume":"12","author":"Alvarez","year":"2011","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.biopha.2017.01.030_bib0080","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1038\/emboj.2011.312","article-title":"Signalling pathway for RKIP and Let\u20107 regulates and predicts metastatic breast cancer","volume":"30","author":"Yun","year":"2011","journal-title":"EMBO J."},{"key":"10.1016\/j.biopha.2017.01.030_bib0085","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nature04524","article-title":"Regulation of cancer cell migration and bone metastasis by RANKL","volume":"440","author":"Jones","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2017.01.030_bib0090","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/bjc.1987.13","article-title":"The clinical course of bone metastases from breast cancer","volume":"55","author":"Coleman","year":"1987","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2017.01.030_bib0095","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.3892\/or.2012.1645","article-title":"microRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN","volume":"27","author":"Zhang","year":"2012","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.biopha.2017.01.030_bib0100","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.semcancer.2008.01.002","article-title":"A role for microRNAs in the development of the immune system and in the pathogenesis of cancer","volume":"18","author":"Kanellopoulou","year":"2008","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.biopha.2017.01.030_bib0105","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.molmed.2008.07.001","article-title":"let-7 microRNAs in development stem cells and cancer","volume":"14","author":"B\u00fcssing","year":"2008","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.biopha.2017.01.030_bib0110","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1208\/s12248-010-9194-0","article-title":"microRNA and cancer","volume":"12","author":"Li","year":"2010","journal-title":"AAPS J."},{"key":"10.1016\/j.biopha.2017.01.030_bib0115","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/sj.neo.7900135","article-title":"Jun N-terminal kinase 1 mediates transcriptional induction of matrix metal loproteinase 9 expression","volume":"3","author":"Crowe","year":"2001","journal-title":"Neoplasia"},{"key":"10.1016\/j.biopha.2017.01.030_bib0120","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nrc745","article-title":"New functions for the matrix metalloproteinases in cancer progression","volume":"2","author":"Egeblad","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2017.01.030_bib0125","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00001622-200103000-00006","article-title":"Role of cadherins and matrixins in melanoma","volume":"13","author":"Gruss","year":"2001","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.biopha.2017.01.030_bib0130","first-page":"237","article-title":"A novel role of metalloproteinase in cancer-mediated immunosuppression","volume":"61","author":"Sheu","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2017.01.030_bib0135","first-page":"2253","article-title":"Elevated levels of serum and plasma metalloproteinases in patients with gastric cancer","volume":"17","author":"Endo","year":"1996","journal-title":"Anticancer Res."},{"key":"10.1016\/j.biopha.2017.01.030_bib0140","first-page":"1058","article-title":"Elevated plasma levels of matrix metalloproteinase\u20109 (92\u2010kd type IV collagenase\/gelatinase B) in hepatocellular carcinoma","volume":"24","author":"Hayasaka","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2017.01.030_bib0145","first-page":"140","article-title":"Mr 92 000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer","volume":"53","author":"Zucker","year":"1993","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2017.01.030_bib0150","first-page":"1355","article-title":"Expression of matrix metalloproteinases (MMPs) in primary human breast cancer: MMP-9 as a potential biomarker for cancer invasion and metastasis","volume":"34","author":"Merdad","year":"2014","journal-title":"Anticancer Res."},{"key":"10.1016\/j.biopha.2017.01.030_bib0155","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/35065016","article-title":"Involvement of chemokine receptors in breast cancer metastasis","volume":"410","author":"M\u00fcller","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2017.01.030_bib0160","doi-asserted-by":"crossref","first-page":"ra60","DOI":"10.1126\/scisignal.2002221","article-title":"A synthetic biology approach reveals a CXCR4-G13-Rho signaling axis driving transendothelial migration of metastatic breast cancer cells","volume":"4","author":"Yagi","year":"2011","journal-title":"Sci. Signal."},{"key":"10.1016\/j.biopha.2017.01.030_bib0165","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1158\/1541-7786.MCR-11-0498","article-title":"New insight into the SDF-1\/CXCR4 axis in a breast carcinoma model: hypoxia-induced endothelial SDF-1 and tumor cell CXCR4 are required for tumor cell intravasation","volume":"10","author":"Jin","year":"2012","journal-title":"Mol. Cancer Res."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332216316341?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332216316341?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T12:17:05Z","timestamp":1778242625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332216316341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":33,"alternative-id":["S0753332216316341"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2017.01.030","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic effects of bach1 siRNA on human breast adenocarcinoma cell line","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2017.01.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}